Activation of α1 adrenoceptors in ventrolateral orbital cortex attenuates allodynia induced by spared nerve injury in rats. (October 2016)

• Record Type: Journal Article
• Authors: Wei, Lai; Zhu, Yuan-Mei; Zhang, Yu-Xiang; Liang, Feng; Jia, Hong; Qu, Chao-Ling; Wang, Jing; Tang, Jing-Shi; Lu, She-Min; Huo, Fu-Quan; Yan, Chun-Xia
• Is Part Of: Neurochemistry international. Volume 99(2016)
• Page Start: 85
• Page End: 93
• Publication Date: 2016-10
• Subjects: α1 adrenoceptor -- Neuropathic pain -- Ventrolateral orbital cortex -- Periaqueductal gray -- PLC -- PKC; AUC areas under the time-course curve -- Beno benoxathian -- Cl claustrum -- DMSO dimethyl sulfoxide -- DR dorsal raphe nucleus -- fmi forceps minor corpos callosum -- i.p. intraperitoneally -- Meth methoxamine -- KYNA kynurenic acid -- PAG periaqueductal gray -- PLC phospholipase C -- PKC protein kinase C -- PWT paw withdrawal threshold -- Sm thalamic nucleus submedius -- SNI spared nerve injury -- VLO ventrolateral orbital cortex -- vlPAG ventrolateral periaqueductal gray; Neurochemistry -- Periodicals; Neurochemistry -- Periodicals; Neurochimie -- Périodiques; Neurochemistry; Periodicals; 612.804205
• DOI: 10.1016/j.neuint.2016.06.006
• Languages: English
• ISSNs: 0197-0186

Abstract

Abstract: Recent studies have demonstrated that noradrenaline acting in the ventrolateral orbital cortex (VLO) can potentially reduce allodynia induced by spared nerve injury (SNI), and this effect is mediated by α2 adrenoceptor. The present study examined the effect of the α1 adrenoceptors in the VLO on allodynia induced by SNI in the rats. The mechanical paw withdrawal threshold (PWT) was measured using von-Frey filaments. Microinjection of selective α1 adrenoceptor agonist methoxamine (20, 50, 100 μg in 0.5 μl) into the VLO, contralateral to the site of nerve injury, increased PWT in a dose-dependent manner. This effect was antagonized by pre-microinjection of the selective α1 adrenoceptor antagonist benoxathian into the same VLO site, and blocked by electrolytic lesion of the ventrolateral periaqueductal gray (PAG). Furthermore, pre-administration of non-selective glutamate receptor antagonist kynurenic acid, phospholipase C (PLC) inhibitor U73122, and protein kinase C (PKC) inhibitor chelerythrine to the VLO also blocked methoxamine-induced inhibition of allodynia. These results suggest that activation of α1 adrenoceptors in the VLO can potentially reduce allodynia induced by SNI. This effect may be direct excitation of the VLO neurons, via PLC-PKC signaling pathway, projecting to the PAG or facilitating glutamate release and then indirectly exciting the VLO output neurons projecting to the PAG, leading to activation of the PAG-brainstem descending inhibitory system which depresses the nociceptive transmission at the spinal cord level. Graphical abstract: Highlights: Activation of α1 adrenoceptors attenuates allodynia induced by SNI in the VLO. Electrolytic lesion of PAG eliminates VLO α1 adrenoceptor-mediated antiallodynia. Glutamate receptors are involved in VLO α1 adrenoceptor-mediated antiallodynia. PLC-PKC signal pathway participates in VLO α1 adrenoceptor-mediated antiallodynia.